Non-alcoholic fatty liver disease differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 17: Line 17:
|
|
|Auto Immune Hepatitis  
|Auto Immune Hepatitis  
|More commonly in females
|More commonly in females
|Anti-Nuclear Antibodies,Anti Microsomal Antibodies and Anti Smooth Muscle Anti bodies.
|Anti-Nuclear Antibodies,Anti Microsomal Antibodies and Anti Smooth Muscle Anti bodies.
Line 22: Line 23:
|
|
|α1-antitrypsin deficiency
|α1-antitrypsin deficiency
|Elevated liver enzyme levels  
|Elevated liver enzyme levels  
|α1-antitrypsin level and liver biopsy
|α1-antitrypsin level and liver biopsy
Line 27: Line 29:
|
|
|Wilson disease
|Wilson disease
|Neurologic and psychological 
|Neurologic and psychological 


features.
features at age 40 years.
|ceruloplasmin level and liver biopsy e.t.c.
|-
|
|Hereditary hemochromatosis
|Patient presents with Bronze diabetes, arthritis and
congestive heart failure.
|
|
|}
|}

Revision as of 19:26, 11 December 2017

Non-Alcoholic Fatty Liver Disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Non-Alcoholic Fatty Liver Disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case studies

Case #1

Non-alcoholic fatty liver disease differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Non-alcoholic fatty liver disease differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Non-alcoholic fatty liver disease differential diagnosis

CDC on Non-alcoholic fatty liver disease differential diagnosis

Non-alcoholic fatty liver disease differential diagnosis in the news

Blogs on Non-alcoholic fatty liver disease differential diagnosis

Directions to Hospitals Treating Non-alcoholic fatty liver disease

Risk calculators and risk factors for Non-alcoholic fatty liver disease differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Differential Diagnosis

CAUSE  CLINICAL FEATURES LABORATORY TESTS
Auto Immune Hepatitis More commonly in females Anti-Nuclear Antibodies,Anti Microsomal Antibodies and Anti Smooth Muscle Anti bodies.
α1-antitrypsin deficiency Elevated liver enzyme levels α1-antitrypsin level and liver biopsy
Wilson disease Neurologic and psychological 

features at age 40 years.

ceruloplasmin level and liver biopsy e.t.c.
Hereditary hemochromatosis Patient presents with Bronze diabetes, arthritis and

congestive heart failure.